ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing
-
LiveOne (LVO) Commences 2M Share Buyback
-
LIVEONE ANNOUNCES COMMENCEMENT OF ITS 2 MILLION SHARES STOCK REPURCHASE PROGRAM, STARTING WITH UP TO 500K SHARES
-
Alopexx, Inc (ALPX) Files IPO Registation Statement
-
Snow Lake Resources Announces Closing of Offering of Common Shares by Nova Minerals
-
omniQ Corp (OMQS) and Bridge Bank Enter into Banking Relationship
-
OMNIQ and Bridge Bank enter into a banking relationship. A milestone in creating a stronger balance sheet.
-
OMNIQ and Bridge Bank enter into a banking relationship. A milestone in creating a stronger balance sheet.
-
MAIA Biotechnology (MAIA) Files IPO Registration Statement
-
Snow Lake Resources (LITM) Prices 6M Share Block Trade by Nova Minerals at $6/sh
-
Snow Lake Resources Announces Pricing of Offering of Common Shares by Nova Minerals
-
Alopexx (ALPX) Files IPO Registration Statement
-
Ballantyne Strong (BTN) Files Registration Statement for Proposed IPO of Strong Global Entertainment
-
Ballantyne Strong Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Strong Global Entertainment, Inc.
-
Ballantyne Strong Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Strong Global Entertainment, Inc.
-
Strong Global Entertainment (SGE) Files IPO Registration Statement
-
Permex Petroleum Corporation Announces Closing of USD $7.5 Million Brokered Private Placement
-
Piedmont Announces Closing of Public Offering of Common Stock
-
Piedmont Lithium (PLL) Prices Upsized 1.75M Share Offering at $65/sh
-
Piedmont Announces Pricing of Upsized Public Offering of Common Stock
-
Alopexx, Inc Files IPO Registation Statement
-
OKYO Pharma Limited (OKYO) Files for a US IPO
-
OKYO Pharma Limited ("OKYO" or the "Company") - OKYO publicly files a registration statement with the SEC for a proposed dual-listing on the Nasdaq Capital Market and Offering in the United States
-
OKYO Pharma Limited ("OKYO" or the "Company") - OKYO publicly files a registration statement with the SEC for a proposed dual-listing on the Nasdaq Capital Market and Offering in t
-
OKYO Pharma Limited (OKYO) Files IPO Registration Statement
-
FG Merger Corp. Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
FG Merger Corp. Announces Closing of $70 Million Initial Public Offering
-
IPO for SPAC FG Merger Corp. (FGMC) Opens at $10
-
FG Merger Corp. Prices $70,000,000 Initial Public Offering
-
CEA Industries Announces Closing of $24 Million Public Offering
-
CEA Industries Announces Closing of $24 Million Public Offering
-
CEA Industries Inc (CEAD) Prices 5.81M Share and Warrant Offering at $4.13/sh
-
CEA Industries Announces Pricing of $24 Million Public Offering and Nasdaq Listing
-
CEA Industries Announces Pricing of $24 Million Public Offering and Nasdaq Listing
-
UPDATE: Second Sight Medical Products (EYES) and Nano Precision Medical Announce Merger Agreement
-
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
-
Eleison Pharmaceuticals (ELSN) Files IPO Registration Statement
-
Forza X1 (FRZA) Files IPO Registration Statement
-
Snow Lake Resources Ltd. Letter to Shareholders
-
Immix Biopharma, Inc. Announces Closing of Initial Public Offering
-
Immix Biopharma, Inc. Announces Closing of Initial Public Offering
-
Immix Biopharma (IMMX) IPO Opens Flat
-
Immix Biopharma (IMMX) Prices 4.2M Share IPO at $10/sh
-
Immix Biopharma, Inc. Announces Pricing of Initial Public Offering
-
Immix Biopharma, Inc. Announces Pricing of Initial Public Offering
-
Context Therapeutics (CNTX) Announces Closing of $31.25 Million Private Placement of Common Stock, Warrants
-
Context Therapeutics Inc. Announces Closing of $31.25 Million Private Placement
-
Context Therapeutics Inc. Announces Closing of $31.25 Million Private Placement
-
Hagerty, Inc. (HGTY) to Debut on NYSE, Following Completion of SPAC Merger
-
Hagerty Debuts Today as a Publicly Traded Company on the New York Stock Exchange After Completing Business Combination with Aldel Financial

